Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. That said, here is one profitable company that generates reliable profits without sacrificing growth and two best left off your watchlist.
Two Stocks to Sell:
Warner Music Group (WMG)
Trailing 12-Month GAAP Operating Margin: 13.7%
Launching the careers of legendary artists like Frank Sinatra, Warner Music Group (NASDAQ: WMG) is a music company managing a diverse portfolio of artists, recordings, and music publishing services worldwide.
Why Do We Avoid WMG?
- Lackluster 7.7% annual revenue growth over the last five years indicates the company is losing ground to competitors
- Forecasted free cash flow margin suggests the company will fail to improve its cash conversion over the next year
- Eroding returns on capital from an already low base indicate that management’s recent investments are destroying value
At $27.63 per share, Warner Music Group trades at 15.7x forward P/E. Dive into our free research report to see why there are better opportunities than WMG.
Inspire Medical Systems (INSP)
Trailing 12-Month GAAP Operating Margin: 6%
Offering an alternative for the millions who struggle with traditional CPAP machines, Inspire Medical Systems (NYSE: INSP) develops and sells an implantable neurostimulation device that treats obstructive sleep apnea by stimulating nerves to keep airways open during sleep.
Why Are We Wary of INSP?
- Revenue base of $898.7 million puts it at a disadvantage compared to larger competitors exhibiting economies of scale
- Forecasted revenue decline of 3.5% for the upcoming 12 months implies demand will fall off a cliff
Inspire Medical Systems is trading at $70.70 per share, or 51.6x forward P/E. Check out our free in-depth research report to learn more about why INSP doesn’t pass our bar.
One Stock to Watch:
Colgate-Palmolive (CL)
Trailing 12-Month GAAP Operating Margin: 14.9%
Formed after the 1928 combination between toothpaste maker Colgate and soap maker Palmolive-Peet, Colgate-Palmolive (NYSE: CL) is a consumer products company that focuses on personal, household, and pet products.
Why Is CL Interesting?
- Dominant market position is represented by its $21.04 billion in revenue, which gives it negotiating power with suppliers and retailers
- Products command premium prices and lead to a best-in-class gross margin of 60.5%
- Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends, and its rising cash conversion increases its margin of safety
Colgate-Palmolive’s stock price of $85.80 implies a valuation ratio of 21.5x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
